Form 4: USANA Health Sciences Director Acquires Shares

USANA Health Sciences Director John Turman Fleming acquired 1,057 restricted stock units on April 23, 2026, increasing his beneficial ownership.

Summary

• John Turman Fleming, a Director at USANA Health Sciences Inc. (USNA), acquired 1,057 restricted stock units (RSUs) on April 23, 2026.
• These RSUs represent a contingent right to receive one share of USNA common stock.
• Following this transaction, Fleming beneficially owns 6,680 shares of common stock.
• The RSUs vest in four equal installments, with the final vesting date on April 23, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as director stock acquisitions can signal confidence, but it does not represent new financial performance data.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 1,057 restricted stock units indicates continued alignment of management and director interests with shareholders.

Future Outlook

The filing does not contain forward-looking statements or guidance. The acquisition of restricted stock units suggests a long-term commitment from the director.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of restricted stock units by a director, are common in the health sciences and direct selling industries. These actions are often viewed by the market as indicators of management's belief in the company's stability and growth potential.

Stakeholder Impact

• Shareholders: The acquisition may be viewed positively as it aligns director interests with shareholders, potentially indicating confidence in the company's future performance.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Restricted Stock Units, Director Acquisition, Beneficial Ownership